1st Quarter - Report

TIBER CREEK HEALTH STRATEGIES, INC. for PECK MADIGAN JONES (ON BEHALF OF ROIVANT SCIENCES, INC.)

Firm
Client
Income
—
Expenses
—

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to the development of gene therapies

LobbyistCovered position, as disclosed
JAMES BRYANT HALL —

Contacted: SENATE

Pharmacy PHA

Issues related to the development of gene therapies

LobbyistCovered position, as disclosed
JAMES BRYANT HALL —

Contacted: SENATE

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
ROIVANT SCIENCES GMBH Switzerland Switzerland — —
ROIVANT SCIENCES LTD. Bermuda United Kingdom 100.0% —
ROIVANT SCIENCES HOLDINGS LTD. United Kingdom United Kingdom 100.0% —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.